Lipoprotein Lipase anticorps (AA 28-475)

N° du produit ABIN2724821

Cet anticorps anti-Lipoprotein Lipase Monoclonal Souris (Clone 6B4) (ABIN2724821) détecte spécifiquement Lipoprotein Lipase dans WB. L’anticorps est réactif avec des échantillons de Humain.

Aperçu rapide pour Lipoprotein Lipase anticorps (AA 28-475) (ABIN2724821)

Antigène: Lipoprotein Lipase (LPL)

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp Lipoprotein Lipase est non-conjugé

Application: Western Blotting (WB)

Clone: 6B4

Détail du produit anti-Lipoprotein Lipase anticorps

Épitope: AA 28-475

Attributs du produit: Homo sapiens lipoprotein lipase (LPL)

Purification: Purified from mouse ascites fluids by affinity chromatography

Immunogène: Human recombinant protein fragment corresponding amino acids 28-475 of human LPL(NP_000228) produced in E.coli.

Isotype: IgG1

Information d'application

Indications d'application: WB 1:2000,

Commentaires:

The concentration of the product may vary between diferrent lots.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.5-1.0 mg/mL

Buffer: PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Détails sur Lipoprotein Lipase

Antigène: Lipoprotein Lipase (LPL)

Autre désignation: LPL

Sujet: LPL encodes lipoprotein lipase, which is expressed in heart, muscle, and adipose tissue. LPL functions as a homodimer, and has the dual functions of triglyceride hydrolase and ligand/bridging factor for receptor-mediated lipoprotein uptake. Severe mutations that cause LPL deficiency result in type I hyperlipoproteinemia, while less extreme mutations in LPL are linked to many disorders of lipoprotein metabolism.

Poids moléculaire: 50.3 kDa

ID gène: 4023

NCBI Accession: NM_000237

HGNC: 4023

Pathways: Lipid Metabolism